Novel Platinum-Based Drug (HJ-550 )

Hong Kong – Overseas Projects Platform / Signature Project
Hong Kong – Overseas Projects Platform / Signature Project
About this project
A first-in-class targeted bivalent platinum drug exhibits overall superior efficacy over first-line standard-of-care treatments as monotherapy and in combination, holding potential to transform first-line tumor therapeutic strategies.
Help us to improve